RTX back in the spotlight after $22.9 billion Missile contract points to production ramp-up

RTX is drawing fresh market attention after a report highlighted a sizable U.S. contract routed through the company’s Raytheon business unit to expand Tomahawk missile production. The agreement, described as valued at $22.9 billion over seven years, is framed as part of a broader effort by the U.S. military to accelerate inventory building for long-range strike capabilities.

In the account, the contract is expected to increase Tomahawk production from about 60 missiles per year to as many as 1,000 annually. That kind of step-change matters to defense contractors because missile programs often run for years and depend on long lead times for components, production lines, and government acceptance schedules.

The report also ties the potential production ramp to backlog and valuation concerns, arguing that RTX’s market price may not fully reflect the scale of the new work. It notes that RTX shares were trading around $212.08 at the time of publication on Aug. 28, presenting the contract as a catalyst that could alter investor expectations for future revenue and cash generation.

While the report’s framing centers on “undervaluation,” it does not, in the information provided here, lay out a detailed methodology such as discounted cash flow assumptions, backlog-to-revenue timing, or comparisons to peers’ defense backlog multiples. It also does not specify whether the $22.9 billion figure is the total contract value including all options, the portion already booked, or how much of the contract is expected to fall into which fiscal years.

RTX’s defense exposure is largely associated with long-running, high-dollar programs where governments place orders over multiple years and production must be scaled to meet both near-term readiness needs and longer-term sustainment. In that context, contract announcements tied to higher output rates can influence the outlook for backlog growth, utilization of manufacturing capacity, and the pace at which deliveries translate into recognized revenue.

For investors and analysts, the practical question is not only the topline size of the award but also how quickly the increased output rate can be achieved and maintained. Production ramps can be constrained by supply-chain availability, qualification and test timelines, and acceptance processes, any of which can affect when the higher volumes translate into earnings.

It remains unclear from the report details available here whether RTX disclosed additional conditions such as performance milestones, workforce or facility expansion requirements, specific procurement lots, or the share of work that flows through Raytheon versus other RTX operations. The company’s full contract terms, including delivery schedules and the portion already included in reported backlog at the time of publication, would be needed to assess how material the ramp is to near-term financial results.

Going forward, market watchers will likely focus on whether RTX and the U.S. government provide updates on production milestones, deliveries, and cost or schedule metrics tied to the Tomahawk ramp. Additional disclosures in investor materials, such as quarterly updates on defense backlog and program execution, may also clarify how management expects the award to flow through earnings over the seven-year period.